RxDoctor Payments Data

Christine Johnston

Infectious Disease · Seattle, WANPI 1104928720

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $26,369 of the $26,799 with a category attached, or 98.4%. GSK accounts for 71.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $16,189 and has fallen 81.3% since, to $3,025 in 2025. Among infectious disease clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,799in general payments, 2019–2025

Across 10 payments — averaging $2679.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$19K
  • Pfizer$3K
  • AbbVie$3K
  • Gilead$2K
  • Modernatx, Inc.$395
  • EMD Serono, Inc.$34
$635,457in research payments, 2019–2025

Across 73 payments — averaging $8704.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$528K
  • GSK$103K
  • Pfizer$4K

What the payments were for

  • Consulting fees$26,36998%
  • Food & beverage$4292%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK4$19,044
Pfizer1$3,025
AbbVie2$2,800
Gilead1$1,500
Modernatx, Inc.1$395
EMD Serono, Inc.1$34

How this compares

$26,799 in reported general payments places this provider in the 90th percentile of 186 infectious disease providers in Washington.

See all infectious disease providers in Washington →

Other infectious disease in Seattle

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →